MedTrace Logo

Pulmonary Resistance in Fontan Who Have Undergone Heart Transplantation

NCT00268047 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2011-07-06

No results posted yet for this study

Summary

Clinical evidence reveals that some patients who undergo cardiac transplantation exhibit problems with pulmonary vascular resistance as well. In some studies, an increase in pulmonary vascular resistance has been used as an indicator for increased 3-day and 3-month mortality after heart transplantation2. In this study, the investigators would like to look at pulmonary vascular resistance in patients with a surgical history of the Fontan procedure followed by heart transplantation.

Conditions

  • Congenital Disorders

Sponsors & Collaborators

  • Children's Healthcare of Atlanta

    lead OTHER

Principal Investigators

  • Kirk R. Kanter, MD · Emory Univ. SOM Cardiothoracic Surgery at Children's Healthcare of Atlanta

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00268047 on ClinicalTrials.gov